Telehealth & Digital Health

At BIO 2026, Transpire Bio isn't just presenting; it's pitching a new paradigm for medicine, using inhalation to tackle everything from diabetes to cancer.

A half-million dollar grant is just the start. A new public-private alliance is mobilizing to fight blast-induced brain injuries. Here's the story behind the numbers.

A new report projects the wellness market will hit $12.9T by 2031. This isn't just about yoga mats; it's a tech-fueled, Asia-led economic realignment.

After a 20-year drought, positive Phase 3 data for oral olorofim signals a safer, potent new option against a deadly fungus, promising a major market shake-up.

A landmark partnership aims to bring data-driven transparency to senior care, combining industry ratings with a national PR campaign to redefine quality.

Internet titan MrBeast is leveraging his billion-follower empire to tackle a critical blood shortage, aiming to save 1,000 lives in a single day.

GSK and Spero Therapeutics have won FDA approval for Utebzi, the first oral carbapenem for complex UTIs, a move that could slash healthcare costs.

Delisted and facing market headwinds, Allurion is executing a reverse stock split. Can this financial maneuver revive its stock and fund its U.S. expansion?

With a $110M boost, Nyxoah is bringing its innovative, battery-free sleep apnea device to the US. Is this the disruption patients have been waiting for?

A partnership between Chef Carla Hall and The Fresh Market shows how retail fundraising directly enables cutting-edge diagnostics and treatments in the fight against Alzheimer's.

A strategic hire signals a new phase for Swisslog Healthcare, betting that expert storytelling is the key to unlocking the full potential of its robotic solutions.

Central Garden & Pet's latest launch isn't just a cat treat; it's a calculated move into the underserved, high-growth feline calming market. Here's the strategy.

The hiring of Mark Whalen isn't just a personnel move; it's Banner Health's play to scale its nonprofit, value-based care network across the American West.

A Florida hospital just rebuilt a baby's heart in stages. It's not just a medical first; it's a new blueprint for innovation where execution trumps hype.

Model N's acquisition of Kalderos targets the chaotic 340B drug discount program, a system where 99% of pharma leaders lack real-time data visibility.

As it marks 70 years, NUNM's move to a new downtown campus is more than a milestone—it's a strategic investment in Portland's struggling urban core.

A new partnership brings clinical AI to thousands of independent practices, promising to slash administrative costs and give doctors back their most valuable asset: time.

A new network aims to speed up clinical trials by recruiting patients from med spas and longevity clinics. Is this the future of medicine or a risky new frontier?

Thoreau's major investment in Ensemble signals a tech-fueled future for healthcare RCM, aiming to slash costs and boost efficiency with advanced AI.

As Canada’s caregiver crisis deepens, a new platform launches to coordinate family support, putting older adults back in control of their own lives.